Clinical Trials Browser

Interventional × humanized 3F8 anti-GD2 monoclonal antibody × Dermatologic × Clear all

NCT00743496 2017-08-17

A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma

Phase 1 Completed

CNSDermatologicSarcoma

Melanoma, Neuroblastoma, Sarcoma, Ewing, Osteosarcoma